For instance, MEF2C was identified as a candidate gene/molecular marker for the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) and evaluated by RT-PCR. The gene discussed is MEF2C; the disease is invasive ductal breast carcinoma.